Primary Site >> Colorectal Cancer

Gene >> PDGFRB

Journal: Virchows Arch B Cell Pathol Incl Mol Pathol. 1990;59(3):173-8.
Title: Expression of several growth factors and their receptor genes in human colon carcinomas.
Author: Ito, M|Yoshida, K|Kyo, E|Ayhan, A|Nakayama, H|Yasui, W|Ito, H|Tahara, E
PMID: 1980764
Journal: Int J Cancer. 1995 Mar 16;60(6):791-7.
Title: Receptor tyrosine kinases expressed in metastatic colon cancer.
Author: Craven, R J|Xu, L H|Weiner, T M|Fridell, Y W|Dent, G A|Srivastava, S|Varnum, B|Liu, E T|Cance, W G
PMID: 7896447
Journal: Oncogene. 1995 Mar 2;10(5):891-5.
Title: Isolation of a candidate tumor suppressor gene on chromosome 8p21.3-p22 that is homologous to an extracellular domain of the PDGF receptor beta gene.
Author: Fujiwara, Y|Ohata, H|Kuroki, T|Koyama, K|Tsuchiya, E|Monden, M|Nakamura, Y
PMID: 7898930
Journal: J Med Chem. 1997 Feb 14;40(4):413-26.
Title: Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
Author: Showalter, H D|Sercel, A D|Leja, B M|Wolfangel, C D|Ambroso, L A|Elliott, W L|Fry, D W|Kraker, A J|Howard, C T|Lu, G H|Moore, C W|Nelson, J M|Roberts, B J|Vincent, P W|Denny, W A|Thompson, A M
PMID: 9046331
Journal: Semin Surg Oncol. 1998 Jan-Feb;14(1):3-12.
Title: Molecular changes during the genesis of human gliomas.
Author: Sehgal, A
PMID: 9407626
Journal: Biochem Pharmacol. 2000 Oct 1;60(7):885-98.
Title: Biochemical and cellular effects of c-Src kinase-selective pyrido[2, 3-d]pyrimidine tyrosine kinase inhibitors.
Author: Kraker, A J|Hartl, B G|Amar, A M|Barvian, M R|Showalter, H D|Moore, C W
PMID: 10974196
Journal: Biochim Biophys Acta. 2001 Feb 16;1525(1-2):191-6.
Title: Construction of tumor-specific cells expressing a membrane-anchored single-chain Fv of anti-ErbB-2 antibody.
Author: Suzuki, M|Shinkai, M|Honda, H|Kamihira, M|Iijima, S|Kobayashi, T
PMID: 11342269
Journal: Curr Med Chem. 2001 Oct;8(12):1487-503.
Title: Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents.
Author: Owa, T|Yoshino, H|Yoshimatsu, K|Nagasu, T
PMID: 11562278
Journal: J Biol Chem. 2004 Apr 30;279(18):19335-49. Epub 2004 Feb 12.
Title: Pleckstrin homology and phosphotyrosine-binding domain-dependent membrane association and tyrosine phosphorylation of Dok-4, an inhibitory adapter molecule expressed in epithelial cells.
Author: Bedirian, Arda|Baldwin, Cindy|Abe, Jun-ichi|Takano, Tomoko|Lemay, Serge
PMID: 14963042
Journal: Oncogene. 2004 Feb 26;23(8):1618-26.
Title: Gene expression profiling of human colon xenograft tumors following treatment with SU11248, a multitargeted tyrosine kinase inhibitor.
Author: Morimoto, Alyssa M|Tan, Nguyen|West, Kristina|McArthur, Grant|Toner, Guy C|Manning, William C|Smolich, Beverly D|Cherrington, Julie M
PMID: 14985702
Journal: J Clin Oncol. 2005 Feb 10;23(5):973-81.
Title: Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab', leads to fluid accumulation and is associated with increased tumor vascularized volume.
Author: Jayson, G C|Parker, G J M|Mullamitha, S|Valle, J W|Saunders, M|Broughton, L|Lawrance, J|Carrington, B|Roberts, C|Issa, B|Buckley, D L|Cheung, S|Davies, K|Watson, Y|Zinkewich-Peotti, K|Rolfe, L|Jackson, A
PMID: 15466784
Journal: Cancer Res. 2005 Feb 1;65(3):957-66.
Title: Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451.
Author: Roberts, W Gregory|Whalen, Pamela M|Soderstrom, Erik|Moraski, Garrett|Lyssikatos, Joseph P|Wang, Huifen-F|Cooper, Beth|Baker, Deborah A|Savage, Douglas|Dalvie, Deepak|Atherton, James A|Ralston, Sherry|Szewc, Ruby|Kath, John C|Lin, Jing|Soderstrom, Cathy|T
PMID: 15705896
Journal: Blood Cells Mol Dis. 2005 Mar-Apr;34(2):181-5.
Title: Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor.
Author: Holdhoff, Matthias|Kreuzer, Karl-Anton|Appelt, Christine|Scholz, Regina|Na, Il-Kang|Hildebrandt, Bert|Riess, Hanno|Jordan, Andreas|Schmidt, Christian A|Van Etten, Richard A|Dorken, Bernd|le Coutre, Philipp
PMID: 15727903
Journal: Clin Cancer Res. 2005 May 15;11(10):3633-41.
Title: In vivo target modulation and biological activity of CHIR-258, a multitargeted growth factor receptor kinase inhibitor, in colon cancer models.
Author: Lee, Sang Hoon|Lopes de Menezes, Daniel|Vora, Jayesh|Harris, Alex|Ye, Helen|Nordahl, Lara|Garrett, Evelyn|Samara, Emil|Aukerman, Sharon Lea|Gelb, Arnold B|Heise, Carla
PMID: 15897558
Journal: J Clin Oncol. 2007 Mar 1;25(7):884-96.
Title: Sunitinib: from rational design to clinical efficacy.
Author: Chow, Laura Q M|Eckhardt, S Gail
PMID: 17327610
Journal: J Clin Invest. 2007 Aug;117(8):2114-22.
Title: Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content.
Author: McCarty, Marya F|Somcio, Ray J|Stoeltzing, Oliver|Wey, Jane|Fan, Fan|Liu, Wenbiao|Bucana, Corazon|Ellis, Lee M
PMID: 17641778
Journal: Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1544-50.
Title: mRNA expression of platelet-derived growth factor receptor-beta and C-KIT: correlation with pathologic response to cetuximab-based chemoradiotherapy in patients with rectal cancer.
Author: Erben, Philipp|Horisberger, Karoline|Muessle, Benjamin|Muller, Martin Christian|Treschl, Anne|Ernst, Thomas|Kahler, Georg|Strobel, Philipp|Wenz, Frederik|Kienle, Peter|Post, Stefan|Hochhaus, Andreas|Willeke, Frank|Hofheinz, Ralf-Dieter
PMID: 19028276
Journal: Cancer Res. 2008 Dec 1;68(23):9754-62.
Title: TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic niche.
Author: Yamamoto, Masayoshi|Kikuchi, Hirotoshi|Ohta, Manabu|Kawabata, Toshiki|Hiramatsu, Yoshihiro|Kondo, Kenji|Baba, Megumi|Kamiya, Kinji|Tanaka, Tatsuo|Kitagawa, Masatoshi|Konno, Hiroyuki
PMID: 19047154
Journal: Clin Exp Metastasis. 2008;25(4):477-89.
Title: Targeting the EGFR, VEGFR, and PDGFR on colon cancer cells and stromal cells is required for therapy.
Author: Kuwai, Toshio|Nakamura, Toru|Sasaki, Takamitsu|Kitadai, Yasuhiko|Kim, Jang-Seong|Langley, Robert R|Fan, Dominic|Wang, Xuemei|Do, Kim-Anh|Kim, Sun-Jin|Fidler, Isaiah J
PMID: 18324358
Journal: Mol Cell Proteomics. 2009 Apr;8(4):827-45.
Title: Discovery and scoring of protein interaction subnetworks discriminative of late stage human colon cancer.
Author: Nibbe, Rod K|Markowitz, Sanford|Myeroff, Lois|Ewing, Rob|Chance, Mark R
PMID: 19098285
Journal: Interact Cardiovasc Thorac Surg. 2010 Feb;10(2):228-31.
Title: Tyrosine kinase expression in pulmonary metastases and paired primary tumors.
Author: Muehling, Bernd M|Toelkes, Sara|Schelzig, Hubert|Barth, Thomas F E|Sunder-Plassmann, Ludger
PMID: 19948538
Journal: Tumour Biol. 2010 Apr;31(2):89-96.
Title: Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression.
Author: Sillars-Hardebol, Anke H|Carvalho, Beatriz|de Wit, Meike|Postma, Cindy|Delis-van Diemen, Pien M|Mongera, Sandra|Ylstra, Bauke|van de Wiel, Mark A|Meijer, Gerrit A|Fijneman, Remond J A
PMID: 20358421
Journal: Biochem Biophys Res Commun. 2010 Jul 23;398(2):205-11.
Title: Sunitinib deregulates tumor adaptation to hypoxia by inhibiting HIF-1alpha synthesis in HT-29 colon cancer cells.
Author: Shin, Hyun-Woo|Cho, Chung-Hyun|Kim, Tae-You|Park, Jong-Wan
PMID: 20599738
Journal: Cancer Biol Ther. 2010 Oct 1;10(7):682-5. Epub 2010 Oct 1.
Title: Angiogenic cells, macroparticles and RNA transcripts in laparoscopic vs open surgery for colorectal cancer.
Author: Bono, Anna|Bianchi, Paolo|Locatelli, Andrea|Calleri, Angelica|Quarna, Jessica|Antoniott, Pierluigi|Rabascio, Cristina|Mancuso, Patrizia|Andreoni, Bruno|Bertolini, Francesco
PMID: 20676027
Journal: J Med Chem. 2010 Nov 25;53(22):8140-9.
Title: Novel potent orally active multitargeted receptor tyrosine kinase inhibitors: synthesis, structure-activity relationships, and antitumor activities of 2-indolinone derivatives.
Author: Cho, Tang Peng|Dong, Su Yi|Jun, Feng|Hong, Fu Jian|Liang, Yang Jiang|Lu, Xiao|Hua, Peng Jiang|Li, Li Ya|Lei, Zhang|Bing, Hu|Ying, Zhou|Qiong, Li Fang|Bei, Fu Bei|Guang, Lou Li|Shen, Gong Ai|Hong, She Gao|Hong, Sun Wei|Tai, Mong Xian
PMID: 21028894
Journal: Curr Drug Targets. 2011 Apr;12(4):563-78.
Title: Dasatinib: an anti-tumour agent via Src inhibition.
Author: Gnoni, Antonio|Marech, Ilaria|Silvestris, Nicola|Vacca, Angelo|Lorusso, Vito
PMID: 21226671
Journal: Clin Cancer Res. 2011 Sep 1;17(17):5546-52.
Title: Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors.
Author: Montero, Juan Carlos|Seoane, Samuel|Ocana, Alberto|Pandiella, Atanasio
PMID: 21670084
Journal: Cell Physiol Biochem. 2011;27(5):565-74.
Title: SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo.
Author: Cao, Zhi-Xing|Zheng, Ren-Lin|Lin, Hong-Jun|Luo, Shi-Dong|Zhou, Yan|Xu, You-Zhi|Zeng, Xiu-Xiu|Wang, Zhao|Zhou, Li-Na|Mao, Yong-Qiu|Yang, Li|Wei, Yu-Quan|Yu, Luo-Ting|Yang, Sheng-Yong|Zhao, Ying-Lan
PMID: 21691074
Journal: Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):17135-40.
Title: Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/beta-catenin signaling.
Author: Scholer-Dahirel, Alix|Schlabach, Michael R|Loo, Alice|Bagdasarian, Linda|Meyer, Ronald|Guo, Ribo|Woolfenden, Steve|Yu, Kristine K|Markovits, Judit|Killary, Karen|Sonkin, Dmitry|Yao, Yung-Mae|Warmuth, Markus|Sellers, William R|Schlegel, Robert|Stegmeier, F
PMID: 21949247
Journal: PLoS One. 2011;6(12):e28841.
Title: Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors.
Author: Morgillo, Floriana|Martinelli, Erika|Troiani, Teresa|Orditura, Michele|De Vita, Ferdinando|Ciardiello, Fortunato
PMID: 22174910
Journal: Cancers (Basel). 2011 May 25;3(2):2501-15.
Title: Activation of PDGFr-beta Signaling Pathway after Imatinib and Radioimmunotherapy Treatment in Experimental Pancreatic Cancer.
Author: Abe, Michio|Kortylewicz, Zbigniew P|Enke, Charles A|Mack, Elizabeth|Baranowska-Kortylewicz, Janina
PMID: 24212821
Journal: BMC Cancer. 2012 Nov 12;12:514.
Title: PDGFRalpha/beta and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome.
Author: Estevez-Garcia, Purificacion|Castano, Angel|Martin, Ana C|Lopez-Rios, Fernando|Iglesias, Joaquin|Munoz-Galvan, Sandra|Lopez-Calderero, Iker|Molina-Pinelo, Sonia|Pastor, Maria D|Carnero, Amancio|Paz-Ares, Luis|Garcia-Carbonero, Rocio
PMID: 23146028
Journal: Expert Opin Investig Drugs. 2012 Jun;21(6):879-89.
Title: Regorafenib for cancer.
Author: Strumberg, Dirk|Schultheis, Beate
PMID: 22577890
Journal: Hum Mol Genet. 2012 Feb 15;21(4):934-46.
Title: Refinement of the associations between risk of colorectal cancer and polymorphisms on chromosomes 1q41 and 12q13.13.
Author: Spain, Sarah L|Carvajal-Carmona, Luis G|Howarth, Kimberley M|Jones, Angela M|Su, Zhan|Cazier, Jean-Baptiste|Williams, Jennet|Aaltonen, Lauri A|Pharoah, Paul|Kerr, David J|Cheadle, Jeremy|Li, Li|Casey, Graham|Vodicka, Pavel|Sieber, Oliver|Lipton, Lara|Gibb
PMID: 22076443
Journal: Clin Cancer Res. 2012 May 1;18(9):2658-67.
Title: A phase I dose-escalation study of regorafenib (BAY 73-4506), an inhibitor of oncogenic, angiogenic, and stromal kinases, in patients with advanced solid tumors.
Author: Mross, Klaus|Frost, Annette|Steinbild, Simone|Hedbom, Susanne|Buchert, Martin|Fasol, Ulrike|Unger, Clemens|Kratzschmar, Jorn|Heinig, Roland|Boix, Oliver|Christensen, Olaf
PMID: 22421192
Journal: Int J Cancer. 2013 Feb 15;132(4):813-23.
Title: Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer.
Author: Shinagawa, Kei|Kitadai, Yasuhiko|Tanaka, Miwako|Sumida, Tomonori|Onoyama, Mieko|Ohnishi, Mayu|Ohara, Eiji|Higashi, Yukihito|Tanaka, Shinji|Yasui, Wataru|Chayama, Kazuaki
PMID: 22821812
Journal: Clin Exp Metastasis. 2013 Mar;30(3):309-16.
Title: Protein pathway activation mapping of colorectal metastatic progression reveals metastasis-specific network alterations.
Author: Silvestri, Alessandra|Calvert, Valerie|Belluco, Claudio|Lipsky, Michael|De Maria, Ruggero|Deng, Jianghong|Colombatti, Alfonso|De Marchi, Francesco|Nitti, Donato|Mammano, Enzo|Liotta, Lance|Petricoin, Emanuel|Pierobon, Mariaelena
PMID: 23053743
Journal: Cancer Chemother Pharmacol. 2013 Feb;71(2):321-30.
Title: A phase I trial of imatinib in combination with mFOLFOX6-bevacizumab in patients with advanced colorectal cancer.
Author: Michael, M|Zalcberg, J|Gibbs, P|Lipton, L|Gouillou, M|Jefford, M|McArthur, G|Copeman, M|Lynch, K|Tebbutt, N C
PMID: 23108698
Journal: Cancer Res. 2013 Jan 15;73(2):583-94.
Title: Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesis.
Author: Baker, Ann-Marie|Bird, Demelza|Welti, Jonathan C|Gourlaouen, Morgane|Lang, Georgina|Murray, Graeme I|Reynolds, Andrew R|Cox, Thomas R|Erler, Janine T
PMID: 23188504
Journal: BioDrugs. 2013 Jun;27(3):213-24.
Title: Regorafenib for gastrointestinal malignancies : from preclinical data to clinical results of a novel multi-target inhibitor.
Author: Aprile, Giuseppe|Macerelli, Marianna|Giuliani, Francesco
PMID: 23435872
Journal: Neoplasia. 2013 Feb;15(2):204-17.
Title: PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cells.
Author: Steller, Ernst J A|Raats, Danielle A|Koster, Jan|Rutten, Bert|Govaert, Klaas M|Emmink, Benjamin L|Snoeren, Nikol|van Hooff, Sander R|Holstege, Frank C P|Maas, Coen|Borel Rinkes, Inne H M|Kranenburg, Onno
PMID: 23441134
Journal: Oncotarget. 2013 Jul;4(7):1037-49.
Title: Blockade of the PDGFR family together with SRC leads to diminished proliferation of colorectal cancer cells.
Author: Kaulfuss, Silke|Seemann, Henning|Kampe, Rovena|Meyer, Julia|Dressel, Ralf|Konig, Britta|Scharf, Jens-Gerd|Burfeind, Peter
PMID: 23900414
Journal: Pathol Oncol Res. 2014 Jul;20(3):611-8.
Title: Screening of hub genes and pathways in colorectal cancer with microarray technology.
Author: Wang, Yonggang|Zheng, Tianying
PMID: 24504536
Journal: Mol Cell Proteomics. 2014 Jun;13(6):1471-84.
Title: Discovery of colorectal cancer biomarker candidates by membrane proteomic analysis and subsequent verification using selected reaction monitoring (SRM) and tissue microarray (TMA) analysis.
Author: Kume, Hideaki|Muraoka, Satoshi|Kuga, Takahisa|Adachi, Jun|Narumi, Ryohei|Watanabe, Shio|Kuwano, Masayoshi|Kodera, Yoshio|Matsushita, Kazuyuki|Fukuoka, Junya|Masuda, Takeshi|Ishihama, Yasushi|Matsubara, Hisahiro|Nomura, Fumio|Tomonaga, Takeshi
PMID: 24687888
Journal: Cancer Biomark. 2014;14(2-3):177-84.
Title: The prognostic value of the Na(+)/ H(+) exchanger regulatory factor 1 (NHERF1) protein in cancer.
Author: Saponaro, Concetta|Malfettone, Andrea|Dell'Endice, Teresa Stefania|Brunetti, Anna Elisabetta|Achimas-Cadariu, Patriciu|Paradiso, Angelo|Mangia, Anita
PMID: 24878819
Journal: Yi Chuan. 2014 Jul;36(7):679-84.
Title: Involvement of the CREB5 regulatory network in colorectal cancer metastasis.
Author: Qi, Lu|Ding, Yanqing
PMID: 25076032
Journal: J Zhejiang Univ Sci B. 2014 Aug;15(8):701-12.
Title: Sunitinib mesylate inhibits proliferation of human colonic stromal fibroblasts in vitro and in vivo.
Author: Wang, Zhan-huai|Li, Qiong|Ruan, Shu-qin|Xiao, Qian|Liu, Yue|Hu, Ye-ting|Hu, Li-feng|Chen, Hai-yan|Zheng, Shu|Zhang, Su-zhan|Ding, Ke-feng
PMID: 25091988
Journal: PLoS One. 2015 Nov 23;10(11):e0142612.
Title: Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models.
Author: Daudigeos-Dubus, Estelle|Le Dret, Ludivine|Lanvers-Kaminsky, Claudia|Bawa, Olivia|Opolon, Paule|Vievard, Albane|Villa, Irene|Pages, Melanie|Bosq, Jacques|Vassal, Gilles|Zopf, Dieter|Geoerger, Birgit
PMID: 26599335
Journal: Cancer Biol Ther. 2015;16(12):1726-37.
Title: Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites.
Author: El-Deiry, Wafik S|Vijayvergia, Namrata|Xiu, Joanne|Scicchitano, Angelique|Lim, Bora|Yee, Nelson S|Harvey, Harold A|Gatalica, Zoran|Reddy, Sandeep
PMID: 26553611
Journal: Biochem Pharmacol. 2015 Sep 1;97(1):27-37.
Title: Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia.
Author: To, Kenneth K W|Poon, Daniel C|Wei, Yuming|Wang, Fang|Lin, Ge|Fu, Li-wu
PMID: 26206183
Journal: Neoplasma. 2015;62(6):855-63.
Title: MicroRNA-219-5p functions as a tumor suppressor partially by targeting platelet-derived growth factor receptor alpha in colorectal cancer.
Author: Xiong, G B|Zhang, G N|Xiao, Y|Niu, B Z|Qiu, H Z|Wu, B|Lin, G L|You, L|Shu, H
PMID: 26458304
Journal: Ann Oncol. 2015 Jan;26(1):246-8.
Title: A novel germline mutation of PDGFR-beta might be associated with clinical response of colorectal cancer to regorafenib.
Author: Rechsteiner, M|Wild, P|Kiessling, M K|Bohnert, A|Zhong, Q|Stahel, R A|Moch, H|Curioni-Fontecedro, A
PMID: 25336117
Journal: Pharmacogenomics J. 2015 Feb;15(1):69-76.
Title: Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer.
Author: Volz, N B|Stintzing, S|Zhang, W|Yang, D|Ning, Y|Wakatsuki, T|El-Khoueiry, R E|Li, J E|Kardosh, A|Loupakis, F|Cremolini, C|Falcone, A|Scherer, S J|Lenz, H-J
PMID: 25069475
Journal: Cancer Biol Ther. 2016;17(2):199-207.
Title: EBI-907, a novel BRAF(V600E) inhibitor, has potent oral anti-tumor activity and a broad kinase selectivity profile.
Author: Zhang, Jiayin|Lu, Biao|Liu, Dong|Shen, Ru|Yan, Yinfa|Yang, Liuqing|Zhang, Minsheng|Zhang, Lei|Cao, Guoqing|Cao, Hu|Fu, Beibei|Gong, Aishen|Sun, Qiming|Wan, Hong|Zhang, Lianshan|Tao, Weikang|Cao, Jingsong
PMID: 26810733
Journal: Cancer Sci. 2016 May;107(5):601-8.
Title: Multikinase inhibitor regorafenib inhibits the growth and metastasis of colon cancer with abundant stroma.
Author: Takigawa, Hidehiko|Kitadai, Yasuhiko|Shinagawa, Kei|Yuge, Ryo|Higashi, Yukihito|Tanaka, Shinji|Yasui, Wataru|Chayama, Kazuaki
PMID: 26865419
Journal: Med Oncol. 2016 Oct;33(10):106.
Title: Targeted molecular profiling of rare genetic alterations in colorectal cancer using next-generation sequencing.
Author: Jauhri, Mayank|Bhatnagar, Akanksha|Gupta, Satish|Shokeen, Yogender|Minhas, Sachin|Aggarwal, Shyam
PMID: 27568332
Journal: World J Surg Oncol. 2016 Nov 14;14(1):285.
Title: Perivascular epithelioid cell tumor of the descending colon mimicking a gastrointestinal stromal tumor: a case report.
Author: Iwamoto, Ryuta|Kataoka, Tatsuki R|Furuhata, Ayako|Ono, Kazuo|Hirota, Seiichi|Kawada, Kenji|Sakai, Yoshiharu|Haga, Hironori
PMID: 27842558
Journal: J Gastrointest Oncol. 2017 Feb;8(1):164-172.
Title: Potential actionable targets in appendiceal cancer detected by immunohistochemistry, fluorescent in situ hybridization, and mutational analysis.
Author: Borazanci, Erkut|Millis, Sherri Z|Kimbrough, Jeffery|Doll, Nancy|Von Hoff, Daniel|Ramanathan, Ramesh K
PMID: 28280620
Journal: J Natl Cancer Inst. 2017 Aug 1;109(8). pii: 3064533.
Title: A Novel Diagnostic Tool for Selecting Patients With Mesenchymal-Type Colon Cancer Reveals Intratumor Subtype Heterogeneity.
Author: Ubink, Inge|Elias, Sjoerd G|Moelans, Cathy B|Lacle, Miangela M|van Grevenstein, Wilhelmina M U|van Diest, Paul J|Borel Rinkes, Inne H M|Kranenburg, Onno
PMID: 28376187
Journal: Expert Opin Pharmacother. 2017 Aug;18(11):1153-1162.
Title: The potential role of nintedanib in treating colorectal cancer.
Author: Rossi, Antonio|Latiano, Tiziana Pia|Parente, Paola|Chiarazzo, Cinzia|Limosani, Filomena|Di Maggio, Gabriele|Maiello, Evaristo
PMID: 28649871
Journal: Theranostics. 2017 Jun 1;7(8):2261-2276.
Title: Targeted Delivery to Tumor-associated Pericytes via an Affibody with High Affinity for PDGFRbeta Enhances the in vivo Antitumor Effects of Human TRAIL.
Author: Tao, Ze|Yang, Hao|Shi, Qiuxiao|Fan, Qing|Wan, Lin|Lu, Xiaofeng
PMID: 28740549
Journal: J Pathol Clin Res. 2017 Jul 24;3(3):214-224.
Title: Multi-parametric profiling of renal cell, colorectal, and ovarian cancer identifies tumour-type-specific stroma phenotypes and a novel vascular biomarker.
Author: Corvigno, Sara|Frodin, Magnus|Wisman, G Bea A|Nijman, Hans W|Van der Zee, Ate Gj|Jirstrom, Karin|Nodin, Bjorn|Hrynchyk, Ina|Edler, David|Ragnhammar, Peter|Johansson, Martin|Dahlstrand, Hanna|Mezheyeuski, Artur|Ostman, Arne
PMID: 28770105
Journal: Expert Opin Investig Drugs. 2017 Nov;26(11):1295-1305.
Title: Safety and efficacy of nintedanib for the treatment of metastatic colorectal cancer.
Author: Riesco-Martinez, Maria Carmen|Sanchez-Torre, Ana|Garcia-Carbonero, Rocio
PMID: 28965421
Journal: J Enzyme Inhib Med Chem. 2018 Dec;33(1):546-557.
Title: Anticancer evaluation and molecular modeling of multi-targeted kinase inhibitors based pyrido[2,3-d]pyrimidine scaffold.
Author: Elzahabi, Heba S A|Nossier, Eman S|Khalifa, Nagy M|Alasfoury, Rania A|El-Manawaty, May A
PMID: 29482389
Journal: Oncol Rep. 2018 May;39(5):2178-2184.
Title: Plateletderived growth factor receptorbeta gene expression relates to recurrence in colorectal cancer.
Author: Fujino, Shiki|Miyoshi, Norikatsu|Ohue, Masayuki|Takahashi, Yusuke|Yasui, Masayoshi|Hata, Taishi|Matsuda, Chu|Mizushima, Tsunekazu|Doki, Yuichiro|Mori, Masaki
PMID: 29498405
Journal: Oncol Lett. 2018 May;15(5):6195-6202.
Title: Expression of cancer-associated fibroblast markers in advanced colorectal cancer.
Author: Nishishita, Rie|Morohashi, Satoko|Seino, Hiroko|Wu, Yunyan|Yoshizawa, Tadashi|Haga, Toshihiro|Saito, Kensuke|Hakamada, Kenichi|Fukuda, Shinsaku|Kijima, Hiroshi
PMID: 29616101